Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis

Infection

Volumn 24, Issue 1, 1996, Pages 9-16

  Preac Mursic, V ^a   Marget, W ^a   Busch, U ^a   Pleterski Rigler, D ^b   Hagl, S ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; KINETICS; LYME DISEASE; MALE; NONHUMAN; REACTION TIME; RECURRENT DISEASE; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; AMOXICILLIN; ANIMALS; ANTIBODIES, BACTERIAL; AZITHROMYCIN; BORRELIA BURGDORFERI GROUP; CEFOTAXIME; CEFTRIAXONE; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KINETICS; LYME DISEASE; MALE; MIDDLE AGED; PENICILLIN G; TICKS;

EID: 8944263466     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01780643     Document Type: Article

References (38)

1. Pfister, H.-W., Preac Mursic, V., Wilske, B., Einhäupl, K. M., Weinberger, K.: Latent Lyme neuroborreliosis: presence of Borrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology 39 (1989) 1118-1120.
2. Preac Mursic, V., Weber, K., Pfister, H.-W., Wilske, B., Gross, B., Baumann, A., Prokop, J.: Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17 (1989) 355-359.
3. Liegner, K., Shapiro, J., Ramsay, D. R., Halperin, A. J., Hagrefe, W., Kong, L.: Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infection. J. Am. Acad. Dermatol. 28 (1993) 312-314.
4. Preac Mursic, V., Pfister, H.-W., Spiegel, H., Burk, R., Wilske, B., Reinhardt, S., Boehmer, R.: First isolation of Borrelia burgdorferi from an iris biopsy. J. Clin. Neuroophthalmol. 13 (1993) 155-161.
5. Johnson, R. C., Kodnes, C., Russel, M.: In vitro and in vivo susceptibility of the Lyme disease spirochete Borrelia burgdorferi to four antimicrobials. Antimicrob. Agents Chemother. 31 (1987) 164-167.
6. Johnson, R. C.: Isolation techniques for spirochetes and their sensitivity to antibiotics in vitro and in vivo. Rev. Infect. Dis. 11 (Suppl. 6) (1989) 1505-1510.
7. Preac Mursic, V., Wilske, B., Schierz, G., Holmburger, M., Süß, E.: In vitro and in vivo susceptibility of Borrelia burgdorferi. Eur. J. Clin. Microbiol. 6 (1987) 424-426.
8. Preac Mursic, V.: Antibiotic susceptibility of Borrelia burgdorferi. In vitro and in vivo. In: Weber, K., Burgdorfer, W. (eds.): Aspects of Lyme borreliosis. Springer, Berlin, Heidelberg, New York 1993, pp. 301-311.
9. Levin, J. M., Nelson, J. A., Segreti, J., Harrison, B., Benson, C. A., Strle, F.: In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents. Antimicrob. Agents Chemother. 37 (1993) 1444-1446.
10. Schmidli, J., Hunziker, T., Moesli, P., Schaad, U. B.: Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis. J. Infect. Dis. 158 (1988) 905-906.
11. Häupl, T., Hahn, G., Rittig, M., Krause, A., Schoerner, C., Schönherr, U., Kalden, J. R., Burmester, G. R.: Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis. Arthritis Rheum. 36 (1993) 1621-1626.
12. Liegner, K. B.: Treatment of late Lyme disease: a challenge to accept. J. Clin. Microbiol. 32 (1994) 1415-1416.
13. Preac Mursic, V., Wilske, B., Schierz, G.: European Borrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic susceptibility. Zbl. Bakt. Hyg. A 263 (1986) 112-118.
14. Wilske, B., Preac-Mursic, V.: Microbiological diagnosis of Lyme borreliosis. In: Weber, K., Burgdorfer, W. (eds.): Aspects of Lyme borreliosis. Springer, Berlin, Heidelberg, New York 1993, pp. 267-300.
15. Preac Mursic, V., Wilske, B.: Biology of Borrelia burgdorferi. In: Weber, K., Burgdorfer, W. (eds.): Aspects of Lyme borreliosis. Springer, Berlin, Heidelberg, New York 1993, pp. 44-58.
16. Wilske, B., Preac Mursic, V., Fuchs, R., Bruckbauer, H., Hofmann, A., Zumstein, G., Jauris, S., Soutschek, E., Motz, M.: Immunodominant proteins of Borrelia burgdorferi; implications for improving serodiagnosis of Lyme borreliosis. In: Neu, H. C. (ed.): New antibacterial strategies. Churchill Livingstone, London 1990, pp. 47-63.
17. Casjens, S., Huang, W. M.: Linear chromosomal physical and genetic map of Borrelia burgdorferi, the Lyme disease agent. Molec. Microbiol. 8 (1993) 967-980.
18. Busch, U., Teufel, C. H., Boehmer, R., Wilske, B., Preac-Mursic, V.: Molecular characterization of Borrelia burgdorferi sensu lato strains by pulsed-field gel electrophoresis. Electrophoresis 16 (1995) 744-747.
19. Asbrink, E., Olsson, I., Hovmark, A.: Erythema chronicum migrans afzelius in Sweden. A study on 231 patients. Zbl. Bakt. Hyg. A 263 (1986) 229-236.
20. Steere, A. C., Schoen, R. T., Taylor, E.: The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107 (1987) 725-731.
21. Steere, A. C., Levin, R. E., Molloy, P. J., Kalish, R. A., Abraham III, J. H., Lui, N. Y., Schmid, C. H.: Treatment of Lyme arthritis. Arthritis Rheum. 37 (1994) 878-888.
22. Radolf, J. D., Bourell, K. W., Akins, D. R., Brusca, J. S., Norgard, M. V.: Analysis of Borrelia burgdorferi membrane architecture by freeze-fracture electron microscopy. J. Bacteriol. 176 (1994) 21-31.
23. Swain, R. H. A.: Electron microscopic studies of the morphology of pathogenic spirochaetes. J. Path. Bact. Vol. LXIX (1955) 117-128.
24. Charache, P.: Atypical bacterial forms in human disease. In: Guze, L. B. (ed.): Microbial protoplasts, spheroplasts and L-forms. Williams and Wilkins, Baltimore 1968, p. 484.
25. Stanek, G., Klein, J., Bittner, R., Glogar, D.: Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N. Engl. J. Med. 322 (1990) 249-252.
26. Detmar, U., Maciejewski, W.: Borrelial dermatomyositis-like syndrome. In: Weber, K., Burgdorfer, W. (eds.): Aspects of Lyme borreliosis. Springer, Berlin, Heidelberg, New York 1993, pp. 259-266.
27. Cimmino, M., Azzolini, A., Tobia, F., Pesce, C.: Spirochetes in the spleen of a patient with chronic Lyme disease. Am. J. Clin. Pathol. 91 (1989) 95-97.
28. MacDonald, A. B.: Borrelia in the brains of patients dying with dementia. JAMA 256 (1986) 2195-2196.
29. Dattwyler, R. J., Halperin, J. J., Volkman, D. J., Luft, B. J.: Treatment of late Lyme borreliosis - randomised comparison of ceftriaxone and penicillin. Lancet ii (1988) 1191-1194.
30. Pal, G. S., Baker, J. T., Wright, D. J. M.: Penicillin-resistant borrelia encephalitis responding to cefotaxime. Lancet i (1988) 50-51.
31. Hassler, D., Zöller, L., Haude, M., Hufnagel, H.-D., Heinrich, F., Sonntag, H.-G.: Cefotaxime versus penicillin in the late stage of Lyme disease - prospective, randomized therapeutic study. Infection 18 (1990) 16-20.
32. Kristoferitsch, W., Baumhackl, U., Sluga, E., Stanek, G., Zeller, K.: High-dose penicillin in meningopolyneuritis Garin-Bujadoux-Bannwarth. Zbl. Bakt. Hyg. A 263 (1986) 357-364.
33. Pfister, H.-W., Preac-Mursic, V., Einhäupl, K. M., Wilske, B.: Cefotaxime versus penicillin G for acute neurological manifestations of Lyme borreliosis: a prospective randomized study. Arch. Neurol. 46 (1989) 1190-1194.
34. Weber, K., Preac-Mursic, V., Wilske, B., Thurmayr, R., Neubert, U., Scherwitz, C.: A randomized trial of ceftriaxone versus oral penicillin for treatment of early Lyme borreliosis. Infection 18 (1990) 91-96.
35. Karlsson, M., Hammers-Berggren, S., Lindquist, L., Stiernstedt, G., Svenungsson, B.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44 (1994) 1203-1207.
36. Strle, F., Stanek, G., Ruzic, E., Michieli, M. S.: Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin. Congress for Infectious Diseases, Montreal, Canada, 1990.
37. Pfister, H.-W., Preac Mursic, V., Wilske, B., Schielke, E., Soergel, F., Einhäupl, K. M.: Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J. Infect. Dis. 163 (1991) 311-318.
38. Ying, M., Sturrock, A., Weis, J. J.: Intracellular localization of Borrelia burgdorferi within human emdothelial cells. Infect. Immun. 59 (1991) 671-678.